Literature DB >> 12651820

High stability of markers of cardiovascular risk in blood samples.

Erik J Giltay1, Johanna M Geleijnse, Evert G Schouten, Martijn B Katan, Daan Kromhout.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12651820     DOI： 10.1373/49.4.652

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  15 in total

1.  A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers.

Authors:  Tao Wang; Thomas E Rohan; Marc J Gunter; Xiaonan Xue; Jean Wactawski-Wende; Swapnil N Rajpathak; Mary Cushman; Howard D Strickler; Robert C Kaplan; Sylvia Wassertheil-Smoller; Philipp E Scherer; Gloria Y F Ho
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-03-17       Impact factor: 4.254

2.  Assessment of the effects of repeated freeze thawing and extended bench top processing of plasma samples using untargeted metabolomics.

Authors:  Kelli Goodman; Matthew Mitchell; Anne M Evans; Luke A D Miller; Lisa Ford; Bryan Wittmann; Adam D Kennedy; Douglas Toal
Journal:  Metabolomics       Date:  2021-03-11       Impact factor: 4.290

3.  No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial.

Authors:  E J Giltay; J M Geleijnse; A C Heijboer; J de Goede; L M Oude Griep; M A Blankenstein; D Kromhout
Journal:  Int J Androl       Date:  2012-03-06

4.  Coffee consumption after myocardial infarction and risk of cardiovascular mortality: a prospective analysis in the Alpha Omega Cohort.

Authors:  Laura H van Dongen; Famke Jm Mölenberg; Sabita S Soedamah-Muthu; Daan Kromhout; Johanna M Geleijnse
Journal:  Am J Clin Nutr       Date:  2017-08-23       Impact factor: 7.045

5.  Plasma and Dietary Linoleic Acid and 3-Year Risk of Type 2 Diabetes After Myocardial Infarction: A Prospective Analysis in the Alpha Omega Cohort.

Authors:  Kamalita Pertiwi; Anne J Wanders; Marjolein C Harbers; Leanne K Küpers; Sabita S Soedamah-Muthu; Janette de Goede; Peter L Zock; Johanna M Geleijnse
Journal:  Diabetes Care       Date:  2019-11-14       Impact factor: 19.112

Review 6.  Omega-3 fatty acids and cardiovascular disease: a case for omega-3 index as a new risk factor.

Authors:  William S Harris
Journal:  Pharmacol Res       Date:  2007-01-25       Impact factor: 7.658

7.  Reproducibility of metabolomic profiles among men and women in 2 large cohort studies.

Authors:  Mary K Townsend; Clary B Clish; Peter Kraft; Chen Wu; Amanda L Souza; Amy A Deik; Shelley S Tworoger; Brian M Wolpin
Journal:  Clin Chem       Date:  2013-07-29       Impact factor: 8.327

8.  Effect of omega-3 fatty acids on kidney function after myocardial infarction: the Alpha Omega Trial.

Authors:  Ellen K Hoogeveen; Johanna M Geleijnse; Daan Kromhout; Theo Stijnen; Eugenie F Gemen; Ron Kusters; Erik J Giltay
Journal:  Clin J Am Soc Nephrol       Date:  2014-08-07       Impact factor: 8.237

9.  Effect of Omega-3 Fatty Acid Supplementation on Plasma Fibroblast Growth Factor 23 Levels in Post-Myocardial Infarction Patients with Chronic Kidney Disease: The Alpha Omega Trial.

Authors:  Martin H de Borst; Leandro C Baia; Ellen K Hoogeveen; Erik J Giltay; Gerjan Navis; Stephan J L Bakker; Johanna M Geleijnse; Daan Kromhout; Sabita S Soedamah-Muthu
Journal:  Nutrients       Date:  2017-11-11       Impact factor: 5.717

10.  Targeted metabolomics identifies reliable and stable metabolites in human serum and plasma samples.

Authors:  Michaela Breier; Simone Wahl; Cornelia Prehn; Marina Fugmann; Uta Ferrari; Michaela Weise; Friederike Banning; Jochen Seissler; Harald Grallert; Jerzy Adamski; Andreas Lechner
Journal:  PLoS One       Date:  2014-02-24       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.